Amerise Biosciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 5, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	40	60	44	46	90	109
Market Cap Growth	-32.58%	37.88%	-5.71%	-48.53%	-17.58%	101.22%
Enterprise Value	39	60	45	46	90	121
Last Close Price	0.60	0.91	0.66	0.70	1.36	1.65
PE Ratio	20.19	1054.79	-	-	16.36	-
PS Ratio	10.89	31.98	121.46	525.55	0.94	-64.52
PB Ratio	0.74	1.12	0.81	0.84	1.59	2.14
P/TBV Ratio	0.74	1.12	0.81	0.84	1.59	2.14
P/OCF Ratio	-	1.96	-	-	146.34	-
EV/Sales Ratio	10.83	31.90	124.09	524.95	0.94	-
EV/EBIT Ratio	60.16	768.77	-	-	16.32	-
Debt / Equity Ratio	-	-	-	0.02	0.02	-
Net Debt / Equity Ratio	0.00	0.00	0.00	0.01	0.01	0.00
Asset Turnover	-	0.03	0.01	0.00	1.09	-
Quick Ratio	-	0.01	1.36	0.37	0.99	0.04
Current Ratio	-	0.01	1.48	0.37	0.99	0.04
Return on Equity (ROE)	-	0.11%	-2.68%	-2.13%	10.24%	-6.41%
Return on Assets (ROA)	-	0.07%	-1.65%	-1.18%	3.90%	-3.62%
Return on Invested Capital (ROIC)	1.20%	0.11%	-2.66%	-2.93%	10.12%	-6.44%
Return on Capital Employed (ROCE)	-	0.10%	-2.70%	-3.00%	9.60%	-6.60%
Earnings Yield	1.60%	0.10%	-3.35%	-2.57%	6.11%	-3.09%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.